Dozens of House Democrats are asking HHS and FDA to help maintain access to methotrexate and misoprostol, two medications for which access has been impacted by abortion bans and in the first case a drug shortage, saying the agencies need to take further action to ensure patients can fulfill prescriptions for the drugs. The lawmakers express concern both about cases of patients being denied access to misoprostol and methotrexate because of pharmacists’ concerns they could cause miscarriage or be used...